EXHIBIT 6-62 - EXP.0042.0001.0162 - M. Song, R. Ware, T. Doan and D. Harley, 'Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study' (2020) 64(1) 25 September 2020 Exhibit
EXHIBIT 6-75 - IND.0041.0001.0005 - NHS England, How to support STOMP (Web page) 25 September 2020 Exhibit
EXHIBIT 6-78 - IND.0041.0001.0008 - NHS Health Education England, The Oliver McGowan Mandatory Training in Learning Disability and Autism (Web page) 25 September 2020 Exhibit
EXHIBIT 6-76 - IND.0041.0001.0016 - NHS England, Professional resources (Web page) 25 September 2020 Exhibit
EXHIBIT 6-72 - IND.0041.0001.0019 - NHS England, Stopping Over-Medication of People with a Learning Disability, Autism or Both (STOMP) 25 September 2020 Exhibit
EXHIBIT 6-74 - IND.0041.0001.0031 - NHS England, Stopping over medication of people with a learning disability, autism or both (STOMP) (Web page) 25 September 2020 Exhibit
EXHIBIT 6-77 - IND.0041.0001.0037 - Voluntary Organisations Disability Group, STOMP Pledge for Social Care 25 September 2020 Exhibit
EXHIBIT 6-61 - IND.0047.0001.0017 - A. Nabhanizadeh et al.,'Effectiveness of medication reviews in identifying and reducing medication?related problems among people with intellectual disabilities: A systematic review' (2019) 25 September 2020 Exhibit
EXHIBIT 6-70 - IND.0047.0001.0029 - Royal College of Psychiatrists, Psychotropic drug prescribing for people with intellectual disabilities, mental health problems and/or behaviours that challenge: practice guidelines 25 September 2020 Exhibit
EXHIBIT 6-79 - ISS.001.00331_02 - Pharmaceutical Society of Australia,'Submission to Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability' 25 September 2020 Exhibit
